KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Shares Issued (2019 - 2025)

GoodRx Holdings' Shares Issued history spans 7 years, with the latest figure at $1.2 million for Q4 2025.

  • For Q4 2025, Shares Issued rose 104.09% year-over-year to $1.2 million; the TTM value through Dec 2025 reached $1.3 million, down 93.13%, while the annual FY2025 figure was $1.3 million, 93.13% down from the prior year.
  • Shares Issued for Q4 2025 was $1.2 million at GoodRx Holdings, up from $58000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $17.6 million in Q3 2024 and bottomed at -$3.7 million in Q2 2022.
  • The 5-year median for Shares Issued is $1.2 million (2025), against an average of $3.5 million.
  • The largest annual shift saw Shares Issued surged 2621.03% in 2021 before it crashed 408.94% in 2024.
  • A 5-year view of Shares Issued shows it stood at $5.3 million in 2021, then skyrocketed by 72.62% to $9.2 million in 2022, then plummeted by 132.7% to -$3.0 million in 2023, then surged by 120.4% to $611000.0 in 2024, then soared by 104.09% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Shares Issued are $1.2 million (Q4 2025), $58000.0 (Q3 2025), and $1000.0 (Q2 2025).